Advertisement

In an innovative approach to the Asian market for medical compounds, Teknor Apex has restructured its extensive product portfolio with the goal of offering device designers and manufacturers a multiplicity of raw material options spanning the broadest range of polymer chemistries employed by any custom compounder. The company will introduce this “polymer neutral” medical-market strategy at Medtec China 2014 (Booth P 105).

The company’s medical product offerings include thousands of compounds that meet a wide range of global and regional regulatory, industry, and customer specifications, can be produced in plants around the world, and provide identical performance and code compliance no matter where in the world they are used.

For more information, visit www.teknorapex.com.

Advertisement
Advertisement